Abstract
Hypothyroidism as a sequel to Hashimoto's thyroiditis is a very common thyroid illness. The conventional treatment is replacement of thyroid hormone to compensate insufficient production from the gland. The clinical features manifested is of widely variable intensity and may not be proportionate always to the blood levels of hormones. The disease does not have a direct mention in Ayurvedic classics. In such instances, treatment principle is adopted from the principles of treatment mentioned for those diseases which holds a similarity in etiopathogenesis, based on the clinical presentations and Dosha-Dooshya analysis. Thus, treatment principles of various diseases such as Galagandam, Agnimandyam, Sthoulyam etc., are being used for the treatment of thyroid diseases. A case of hypothyroidism presented with clinical features similar to Pandurogam was managed with the medicines described in the context of Pandurogam and Sopham. Higher TSH levels were brought to normal limits and high anti thyroid peroxidase level was reduced with a set of Ayurvedic medicines for a longer duration. Keeping away from the popular translation of Pandurogam as Anemia, a symptom oriented diagnostic work up based exclusively on the Ayurvedic classics, followed by symptom-oriented selection of medicines suited to the diagnosis is effective in reducing both symptoms and blood values. This gives the hope of managing hypothyroidism with alternate treatment methods other than supplementation of hormone for lifelong.
Keywords: Hypothyroidism, Hashimoto's thyroiditis, Pandurogam, Kanchanara guggulu, Galagandam
1. Introduction
Hormones from thyroid gland has a big influence on every cell, tissues, organs and systems in the body. It regulates the metabolism and deals with energy level of the body. Diseases that affect thyroid glands usually presents either a hyper or hypo activity of the gland. They affect the work efficiency and quality of life of individuals and the productivity of society as a whole. Hypothyroidism is the commonest manifestation among them.
As iodine deficiency is a major cause of thyroid illnesses, iodized salts were used in India since 1983 [1]. In spite of 3 decades of iodization program, hypothyroidism in India is estimated to affect one in ten adults. In spite of easier techniques of detection and inexpensive treatments, it has a higher prevalence (10.95 %) [2] in India compared to UK (3.5 %) [3] or USA (4.6 %) [4] or USA and is generally on an increase globally. Women are nearly 8 times more affected by the illness than men [5].
More than a half of the people that suffers from any thyroid diseases are not aware of their illness. A recent study in a costal district of Kerala showed a prevalence of hypothyroidism in the population as 9.6 %. Most of them were diagnosed for the first time during the study exposing the iceberg phenomenon of undiagnosed hypothyroidism existing in the society. 21 % of the participants who were on medication for hypothyroidism showed higher TSH values reflecting the need for sufficient treatment [6].
Another important cause of hypothyroidism is Hashimoto's thyroiditis, which is a disease of autoimmune origin. Its diagnosis is made by clinical manifestations denoting thyroid under activity and positive anti-thyroid antibodies, along with a small goiter enlargement of the thyroid gland. Their elevated TSH levels are attended with thyroxin (T4) supplementation therapy.
There are said to be some influential factors that modulate the response of levothyroxine (L-T4) replacement dose. Many findings imply that thyroid hormone conversion efficiency is an important factor to the biochemical responses to L-T4. Hence levothyroxine dose escalation may have limited success to raise FT3 to appropriate levels in some cases [7].
Researchers has questions on dependency only on TSH level to regulate the dose of L-T4 treatment. The dynamic equilibrium between TSH and thyroid hormones, especially that of free T3 differ in health and diseases. Hence the realization that the TSH level of a healthy normal population cannot be taken to be ideal for a patient on L-T4 medication [8].
Clinical scoring guides can help to detect hypothyroidism at times, when TSH and T4 alone might place people in an expanding grey area of uncertain diagnosis. In 2003, researchers reconfirmed the usefulness of the 1997 clinical score for hypothyroidism, proving that patients' clinical score, ankle reflex response, total cholesterol, and creatine kinase significantly correlated with T4 and T3 levels. In 2011, a review of thyroid clinical scoring scales reaffirmed their continued relevance for diagnosis [9]. The research found that TSH did not strongly correlate with signs of “tissue hypothyroidism” throughout the body. Symptoms shouldn't have to agree with TSH. Research on the pituitary and hypothalamus has revealed TSH is a unique, local, organ-specific response that cannot speak for the rest of the body's T3 sufficiency.
There are a lot of dissatisfied hypothyroid patients looking for ayurvedic management for the disease. Insufficient relief from the clinical manifestations in spite of well-regulated TSH levels with adequate dose of L-T4 may be one reason for this. Apart from this there might be so many other factors like dislike to the lifelong dependency on medication, sporadic manifestation of side effects, hopes vested with Ayurveda to find alternate choices and so on. In autoimmune thyroiditis, the TPO antibodies hardly ever gets normalised even after keeping good hormonal control for long time. As Ayurveda has shown its effectiveness in many autoimmune diseases, there are increasing hopes to find an effective approach through Ayurveda, in thyroid diseases.
1.1. Case report
A case of Hashimoto's thyroiditis with hypothyroidism was managed based on the clinical complaints presented and their diagnostic analysis based on Ayurvedic texts with marked results. Ayurvedic treatment protocol, tailored to suit the individual situation in a case of hypothyroidism can be so effective when supported with appropriate correlations and interpretations of classical descriptions.
2. Patient information
2.1. De-identified patient data
A female aged 63, living in Thrissur, presented in the out patient department of hospital in June 2023, with a recent blood investigation report of high TSH.
2.2. Patient concerns & symptoms
She had complaints of fatigue, sleepiness, breathlessness, feeling heavy and cloths gets too tight often with a feeling of swelling all over. She approached hospital OP unit searching for alternate options. She was worried about failing to finish her household chores properly.
2.3. Past interventions & outcomes
She was a house wife, apparently well until July 2022, developed neck pain and shoulder pain. Her blood checkup showed hypothyroidism and was put on tab Lethyrox 25mg/day for 3 months. She was also given topical pain relievers, calcium suppliments and Vitamine D supplement. On follow up after 3 months, she was put on Thyronorm 37.5mg/day for 2 months. Anti thyroid peroxidase antibody level was >600 IU/ml, confirming the presence of Hashimoto's thyroiditis. After 2 months the result showed a normal TSH value but persistent symptoms. Generalised swelling, weight gain and fatigue etc., were not relieved while breathlessness and a minimal body pain were also present. She was advised to continue the L.thyroxine at the same dose further. Since 2 or 3 weeks, she felt like the persisting physical complaints were increasing, prompting her to check the TSH value again in May 2023. Her TSH level was found 24.30 IU/ml, in spite of regular dose of Levothyroxine. She was not diabetic, hypertensive or with any other comorbidities and did not have any relevant past history of illnesses.
3. Clinical findings
She had drowsy and fatigued facies. Obese appearance with too tight clothing. Appeared dull and slightly indifferent to conversations. Hair was oily and did not complain of hair loss. There was no swellings or nodules visible or palpable in the neck. Skin was dry and with sporadic scratch marks. She was pale looking and with a body language expressing slight irritability. She was complaining of panting if walked a bit fast, feeling of heaviness all over, prefers to remain silent and to sleep whenever she has an opportunity. Occasional palpitations, constipation, a generalised body pain, feeling fullness of stomach and acid belch often, cold extremities were other complaints. She had an uneventful menopause at the age of 48.
She was from costal region, habituated with sea foods. Although currently suffers from fatigue now, her physical strength and digestive capacity were madhyamam until recently. She had many features showing both Rasadhatu Kshaya such as rookshata, glani etc., and rasavahasrotodushti such as asraddha, hrillasa, gouravam, tandra, angamarda, srotorodha, agninasa etc. Presence of goiter and related manifestations is a feature of mamsavahasrotodushti. Medovahasrotodushti manifests in her as sthoulyam.
The Billewicz diagnostic index [10]. mentioned above was in use at a time when modern methods of diagnosing hypothyroidism were not available. Being easy, inexpensive and reliable, the index is relevant and used even now clinically and for primary screening for prevalent studies etc. [6].
4. Timeline
Her Billiwicz score was assessed at her first visit to substantiate the clinical presentation. Please refer to Table 1. The clinical complaints, lab values and the medicine advised are detailed in Table 2.
Table 1.
Billewicz score.
| Symptoms | Present | Absent | 2-6-23 | 4-10-23 | 9-2-24 | |
|---|---|---|---|---|---|---|
| 1 | Diminished sweating | +6 | −2 | +6 | +6 | +6 |
| 2 | Dry skin | +3 | −6 | +3 | +3 | +3 |
| 3 | Cold intolerance | +4 | −5 | +4 | −5 | −5 |
| 4 | Weight increase | +1 | −1 | +1 | +1 | −1 |
| 5 | Constipation | +2 | −1 | +2 | −1 | −1 |
| 6 | Hoarseness | +5 | −4 | −4 | −4 | −4 |
| 7 | Deafness | +2 | 0 | 0 | 0 | 0 |
| Signs | ||||||
| 8 | Slow movements | +11 | −3 | +11 | +11 | +11 |
| 9 | Coarse skin | +7 | −7 | +7 | +7 | +7 |
| 10 | Cold skin | +3 | −2 | +3 | +3 | +3 |
| 11 | Periorbital puffiness | +4 | −6 | +4 | −6 | −6 |
| 12 | Pulse rate | +4 | −4 | +4 | −4 | −4 |
| 13 | Ankle jerk | +15 | −6 | −6 | −6 | −6 |
| A score of +25 or more suggests hypothyroidism, while a score of −30 or less excludes the disease | 35 | 5 | 4 | |||
Table 2.
Clinical visits and complaints.
| Date | Complaints | Lab values | Medicines followed |
|---|---|---|---|
| 18.7.22 | Fatigue & irritability | TSH 12.51 | |
| FBS 80 mg/dl | |||
| S.Cholesterol 240 mg/dl | |||
| 27.7.22 | Shoulder pain & neck pain, fatigue | TSH 14 | Lethyrox 25mg/day |
| Vitamin D | |||
| Calcium | |||
| Topical pain killer | |||
| 29.7.22 | USG on thyroid reported thyroiditis and a well defined nodule in the isthmus | FNAC showed no malignant cells | |
| 27.10.22 | Shoulder pain & neck pain reduced. | TSH 8.15 | Thyronorm 37.5/day |
| Anti thyroid peroxidase antibody >600 | |||
| 18.1.23 | Body ache, fatigue & weight gain | TSH 0.724 | |
| 29.5.23 | Body ache, fatigue & weight gain, panting | TSH 24.30 | |
| 2-6-23 | Body ache, fatigue & weight gain, panting | Ayurvedic medicines started. Thyronorm continued | |
| 19.7.23 | Feeling comfortable | TSH 1.1 | Thyronorm stopped |
| 3.10.23 | Feeling better | TSH 2.26 | Ayurvedic medicines to continue |
| 9-2-24 | Feeling normal | Anti thyroid peroxidase antibody 180 | |
| 11.3.24 | Feels normal | TSH 3.16 |
5. Diagnostic assessment
5.1. Diagnostic methods
The laboratory tests confirmed the presence of auto-immune thyroiditis and consequent hypothyroidism. Nidana Panchakam (five diagnostic principles) were useful in identifying the disease by matching with known Samprapthi of Ayurvedic classics. Dasavidha Pariksha (tenfold examinations) provided sufficient details of the patient which are necessary to generate a treatment plan based on the diagnosis.
Laboratory tests performed in 2022 and the response to the l-Thyroxine prescribed by the general physician proved the diagnosis of Hashimoto's thyroiditis with hypothyroidism. But the upsurge of TSH value while under medication and aggravation of clinical complaints in 2023, she sought Ayurvedic treatment.
5.2. Diagnostic challenges
Approach of Ayurvedic practitioners to endocrine diseases is a challenge as it varies widely, based on the concepts considered in the diagnostic and treatment discussion. The commonest concepts and approaches in reported treatments bases on the concept of dhatwagni mandya. Correlating goiter with galagandam, hypothyroidism is also treated with medicines mentioned in galaganda chikitsa, like Kanchanara Guggulu. There are patients undergoing panchakarma chikitsa, focusing more on vamana karma, where Vaidya considers hypothyroidism as a kaphadosha dominant status [11]. In another case study reported, patient was provisionally diagnosed as kapha avrita vata (vata obstructed by kapha) with pittaanubandha (associated with pitta) based on the presenting complaints. Here, the treatment protocol containing rookshana, snehana, vamana and virechana followed by shamana & rasayana was also reported to be effective in reducing both TSH and TPO values. There has been case studies of treating hypothyroidism with Yoga & Pranayama. There are case studies focusing on Deepana & Pachana following concepts like agnimandya leading to ama and generation of toxins ending up in the disease [12]. Considering the importance of rasadhatu, kaphadosha, jadharagni and dhatwagni in this disease, use of medicines like arogyavardhini pills are also reported [[13], [14]]. Treatment approaches considering the clinical manifestation and individualised management is also often reported. Sthoulyachikitsa has also been considered as a treatment approach in some reports.
Such wide variations in diagnosis and treatment plan for hypothyroidism is due to wide variations in the clinical presentations in them. The diagnostic approach of Ayurveda prefers to identify the individual and his illness in a larger comprehensive picture, rather than a deficiency of a constituent substance like thyroid hormone. Supplementing the deficient substance is correction of dhatukshaya, hence a part of treatment. Along with that, correction of causes for dhatukshaya and the management of symptoms and complications are equally important. Thus the clinical presentation of the individual was analysed and matched with known samprapti of diseases described.
5.3. Diagnosis
Hypothyroidism is an Anuktavyadhi (a disease manifestations not mentioned in Ayurvedic texts) [15]. The clinical picture patient presented was very similar to the description of panduroga description by Vagbhata [16]. She presented 13 features out of 18 general features described in the context. She also had 6 prodromal features out of 8 poorvaroopa features of panduroga. She presented body ache, swelled up body, loss of taste and dry feel in mouth, blotted abdomen and dry and constipated stools from the list of vata dominant panduroga. Occasional amlaka (acid belch) and tandra (drowsiness) from the list of features of pitta and kapha dominant panduroga features respectively. Please refer to Table 3.
Table 3.
Comparison of features of Pandurogam, Hypothyroidism and those presented by the patient.
| Features of Panduroga | Features in hypothyroidism | Complaints of the patient | |
|---|---|---|---|
| 1 | Gouravam | Weight gain/Feeling heavy | Dress getting tight, feeling heavy, weight gain |
| 2 | Dhatu Saidhilyam | Reduced metabolism | Assumed by presence of hypothyroidism |
| 3 | Oja Gunakshayam | Reduced energy | Loss of initiation to activity |
| 4 | Alpa rakta | Not seen | Not seen |
| 5 | Alpa Medas | Hyper cholesterolemia | Medas getting stagnant in Rakta |
| 6 | Nissara | Not assessable | Not assessable |
| 7 | Sladhendriya | Visual disturbances, hearing impairement, cold touch, constipation, reduced libido, hoarseness of voice, sluggish movements | Cold touch, constipation and slow movements |
| 8 | Anga marda | Generalised body ache | Body ache |
| 9 | Hridravam | Palpitations | Palpitations |
| 10 | Soonakshikootah | Peri orbital edima | Edima present |
| 11 | Sadanah | Fatigue | Fatigue |
| 12 | Kopanah | Irritability | Mild irritability |
| 13 | Shteevanah | Not seen | Not seen |
| 14 | Alpavak | Less talkative | Only answering to questions in few words |
| 15 | Annadvit | Not seen | Not seen |
| 16 | Sisiradweshi | Cold intolerance | Cold intolerance |
| 17 | Seernaromah | Hair fall | Not seen |
| 18 | Hata analah | Reduced metabolism | Assumed by the presence of hypothyroidism |
| Poorvaroopas of Panduroga | |||
| 1 | Hridaya spandanam | Palpitations | Palpitations |
| 2 | Twachi rookshata | Dry & course skin | Dry & course skin |
| 3 | Aruchi | Not seen | Not seen |
| 4 | Peeta mootratwam | Not seen | Not seen |
| 5 | Sweda abhavah | Reduced sweating | Reduced sweating |
| 6 | Alpa vahnita | Not seen | Not seen |
| 7 | Sadah | Tiredness | Tiredness |
| 8 | Sramah | Breathlessness on activity | Breathlessness on activity |
5.3.1. Analysis of symptoms (Samprati-Lakshana Sambandha)
Generalised swelling was the clinical picture the patient presented. This has contributed to the increase in her body weight and also marked subjective feeling of heaviness (Gouravam). Flabby appearance of the body (Dhatu saidhilya – as seen by asamhata Sareera), reduced properties of Ojus (as seen by insecure feelings – Bhibheti).
The conventional and popular translation of the disease Panduroga is anemia. Reduced quantity of Rakta is a feature of Panduroga, which is easily correlated with anemic status. Arunadatta, the commentator says that ‘Raktadhatu’, the refined final produce after the Dhatu Parinama sequence is not generated in Panduroga, instead it stays in the form of Pitta, the waste product [23]. As the patient did not present a deficient haemoglobin status, we assume the kind of pitta involvment in this patient is not in the form of anaemia; instead, fluidity (drava guna of pittadosha) is increased here as seen by the generalised edema.
Reduced quantity of medas is also a feature of panduroga. The stagnation of dhatu parinama sequence is obvious here by the association of hypercholesterolemia with hypothyroidism. Conversion and metabolism of lipids are sluggish since the rasa-rakta dhatus hold the under-utilised, stagnant, higher than normal levels of lipoproteins i.e. derivatives of medo dhatu in blood. Sweat is the waste generated during the conversion of medodhatu. Reduced sweating also shows reduced Dhatu parinama by medodhatwagni. Keeping the dhatusara to the optimal levels will be hampered by reduced Dhatuparinama leading to substantial loss vigour & vitality (Nissarah).
Sladhendriya, another feature of panduroga means the 5 jnanendriyas, 5 karmendriyas and mind are not working in the optimal level. In hypothyroidism, these features are seen in variable intensities manifested as visual disturbances, hearing impairement, cold touch, constipation, reduced libido, hoarseness of voice, sluggish movements etc.
Angamardam or generalised body ache is a vata dominant feature which is frequently seen in rasadhatu related pathologies such as menstrual abnormalities, jwara etc. Hridravam shows the involvement of moolasthana of rasadhadhatu i.e., hridayam and is manifested as palpitations.
Hypothyroidism may cause reduced secretions in stomach and dry mouth due to lesser salivation, leading to reduced taste sensation. Shteevanam (salivation & spitting), hata analah (reduced digestion), aruchi (reduced taste in foods) which are among the general and prodromal features list of Pandurogam, are not among the clinical features of hypothyroidism and not presented in the patient also. Acid belch is not so uncommon in patients taking Levothyroxine regularly. Amlaka is a feature of pittadosha in Panduroga. Thyroiditis, which is the cause of hypothyroidism, itself is an inflammatory pathology, showing a persistant and progressive pachyamana status dominated by pitta dosha. Hence pittadosha shamana by virechana is important here.
Iodine deficiency due to cell damage in autoimmune thyroiditis, causing hypothyroidism shows the reduced nutrient function of rasadhatu. An essential nutrient like iodine is not sufficiently available at the site and the thyroid secretions are not supplied all over the body due to insufficient production. This leads to dhatukshaya in subsequent dhatus like rakta, mamsa etc., triggering vatakopam in those dhatus. Due to reduced metabolic rate and overall activities Vatakshaya happens along with kaphasanchayam happening due to the lack of conversion at rasadhatu.
Accumulation of asthayi rasadhatu shows rasadhatu vikaras due to rasadhatuvridhi. Hence the clinical features of hypothyroidism has features of Rasadushti. Thyroid secretions are related with metabolic functions, which is translated as agni related functions of the body. Since both rasadhatu and raktadhatu are the seat of pittadosha, which has the function of pachanam, and they both travel together in the body with functions of nourishment and metabolism.
When the clinical presentation is with sopham, which is a complication of pandurogam, the samprapthi is more related to raktakshayam and resultant rasavridhi due to increase of asthayi rasadhatu in the rasa-rakta complex. Hence, the clinical manifestations of rasavridhi, in hypothyroidism may be understood as an event during the course of panduroga samprapti. When sopham (inflammation/inflammatory swelling) is presented, it can be taken as panduroga Samprapti has entered into next stage during its course where its upadravas like sopham has set in. At this stage of Samprapti, instead of rasapradoshaja treatments, pandu-sophahara treatments are to be followed. The treatment plan of Panduroga is snehanam, vamanam, srothasodhanam and Shamanam, which clears blockage of channels due to accumulation of rasadhatu and increases the constituents of raktadhatu.
5.3.2. Prognosis
Alternating between hyperthyroidism and hypothyroidism phases before settling finally as hypothyroidism is commonly found in Hashimoto's thyroiditis. Unlike this, after a period of good control on laboratory values with biomedical intervention, worsening clinical complaints and increased TSH prompted her to seek Ayurvedic treatment. Sleshma, twak, rakta & mamsa are the substances getting affected in the pathogenesis of panduroga. Vagbhata says in panduroga, Vaidya should also apply the treatments mentioned in sopham [24]. The features of pandu & sopham are curable here, but the underlying hypothyroidism due to irreversible damage to the organ makes the condition yapyam.
6. Therapeutic interventions
6.1. Type of therapeutic intervention
A Shamana Chikitsa Plan of care was prepared for initial management, with a longer duration of medication in focus. Lekhana, pachana, mrudu virechana with formulations relevant to the diagnosis were selected based on their Rasayana and prasadana potentials.
6.2. Internal medications
The prescription given on 2-6-23 was as follows. (see Table 4)
Table 4.
Initial prescription.
| Sl.No. | Oushadham | Maatra | Anupanam | Frequency | Oushadhakalam |
|---|---|---|---|---|---|
| 1 | Vyoshadi kashayam [17] | 15 ml | Warm water | Twice a day at 6 a.m. and 6 p.m. | In empty stomach |
| 2 | Mandoora Vatakam [18] | 1 tablet | Warm water | Twice a day | After food |
| 3 | Avipathy choornam [19] | 1 teaspoon | Warm water | Once a day | Before supper |
| 4 | Kanchanara Guggulu [20] | 2 tablets | Warm water | Twice a day | After food |
| 5 | Dasamoola hareethaki [21] | 1 big spoon | Nil | Once a day | After supper |
| 6 | Chandraprabha tablets [22] | 2 tablets | Warm water | Twice a day | Before food |
6.3. Changes in therapeutic intervention
On 26-6-23 patient reported occasional mild stomach pain. In addition to the current medications, she was prescribed dadimashtaka choornam [25] −1 tsp with warm water as and when the pain appears. On 3-7-23 she reported good and quick relief from stomach pain when dadimashtaka choornam is taken. On 10-7-23 the patient reported frequent stomach pain and tenesmus in mild intensity. Using avipathy choornam to ensure laxation was stopped and advised to use only as and when required. Dadimashtaka choornam was made a regular daily medicine twice daily before food. This event may be interpreted as a sign of rookshata developed in the koshta as a result of medications.
7. Follow-up and outcomes
The results of intervention were recorded using score sheets before treatment, after medication for 4 months and after medication for 8 months. Refer to Table 5, Table 6.
Table 5.
Zulewski's clinical score for hypothyroidism.
| On the basis of symptoms | Present/Absent | 2-6-23 | 4-10-23 | 9-2-24 | ||
|---|---|---|---|---|---|---|
| 1 | Diminished sweating | Sweating in a warm room | 1/0 | 1 | 1 | 1 |
| 2 | Hoarseness | Speaking voice/singing voice | 1/0 | 0 | 0 | 0 |
| 3 | Parasthesia | Subjective sensation | 1/0 | 0 | 0 | 0 |
| 4 | Dry skin | Dryness of skin noticed spontaneously | 1/0 | 1 | 1 | 1 |
| 5 | Constipation | Bowel habit, use of laxatives | 1/0 | 1 | 0 | 0 |
| 6 | Impairment of hearing | Progressive impairment of hearing | 1/0 | 0 | 0 | 0 |
| 7 | Weight increase | Recorded weight increase/tightness of cloaths | 1/0 | 1 | 0 | 0 |
| Physical signs | ||||||
| 1 | Slow movements | Observe patient movements | 1/0 | 1 | 1 | 1 |
| 2 | Delayed ankle reflex | Observe the relaxation of the reflex | 1/0 | 0 | 0 | 0 |
| 3 | Coarse skin | Examine hands, forearms, elbow, for roughness and thickening of the skin | 1/0 | 1 | 1 | 1 |
| 4 | Periorbital puffiness | This should obscure the curve of the malar bone | 1/0 | 1 | 0 | 0 |
| 5 | Cold skin | Compare temperature of hand with examiners | 1/0 | 1 | 1 | 1 |
| Sum of all signs present | 12/0 | 8 | 5 | 5 | ||
Zulewski et al. set out to re-evaluate the classical signs and symptoms of hypothyroidism in the light of modern laboratory tests. A score >5 points defined hypothyroidism, while a score of 0–2 points defined euthyroid. The score is important for the concept of tissue hypothyroidism, given an easy method of assessing its severity. It can be used to evaluate patients with discordant laboratory results, and to monitor effects of therapy [26].
Table 6.
Clinical improvement score.
| Symptoms | Criteria | Score | 2-6-23 | 4-10-23 | 9-2-24 | |
|---|---|---|---|---|---|---|
| 1 | Puffiness | Absent | 0 | 0 | ||
| occasional | 1 | 1 | ||||
| Periorbital edima/puffiness in the morning every day, relieved in later part of the day | 2 | 2 | ||||
| Persistent | 3 | |||||
| 2 | Edema | Absent | 0 | 0 | ||
| Edema over lower/upper extremities | 1 | 1 | ||||
| Edema over both extremities | 2 | |||||
| Edema all over the body | 3 | 3 | ||||
| 3 | Dry and coarse skin | No dryness | 0 | |||
| Dryness after bath only | 1 | 1 | 1 | 1 | ||
| Dryness relieved by oil application | 2 | |||||
| Dryness not relieved by oil application | 3 | |||||
| 4 | Breathlessness | Absent | 0 | |||
| Occasionally, after strainous workout | 1 | 1 | 1 | |||
| Even climbing stairs, relieved by rest | 2 | |||||
| Felt in routine works like bathing, changing cloths etc | 3 | 3 | ||||
| 5 | Constipation - Frequency | Once a day | 0 | 0 | 0 | |
| Once in two days | 1 | 1 | ||||
| Once in 3 days | 2 | |||||
| Once in more than 3 days | 3 | |||||
| Constipation – Consistancy | Sidhila | 0 | ||||
| Madhyama | 1 | 1 | 1 | |||
| Kathina | 2 | 2 | ||||
| Grandhila | 3 | |||||
| Constipation – Straining | No | 0 | 0 | 0 | ||
| Occasionally/Bearable | 1 | 1 | ||||
| Frequently/Severe | 2 | |||||
| 6 | Weakness | Able to do exercise without difficulty | 0 | 0 | ||
| Able to do mild excercise | 1 | 1 | ||||
| Able to do only mild work | 2 | |||||
| Able to do mild work with difficulty | 3 | 3 | ||||
| Not able to do even mild work | 4 | |||||
| Not able to do even day-to-day routine works | 5 | |||||
| 7 | Lethargy | Finishes work satisfactorily with good vigour and in time | 0 | 0 | 0 | |
| Without desire/unsatisfactorily but in time | 1 | |||||
| Without desire/unsatisfactorily/with lot of mental pressure and not in time | 3 | 3 | ||||
| Doesnot have any initiation and not want to work even after pressure | 4 | |||||
| 8 | Fatigue | Normal | 0 | 0 | 0 | |
| Prefers standing than walking | 1 | |||||
| Prefers sitting than standing | 2 | |||||
| Prefers lying than sitting | 3 | |||||
| Prefers sleeping than lying down | 4 | 4 | ||||
| 9 | Generalised Muscle ache | No ache | 0 | 0 | 0 | |
| Relieved by rest | 1 | |||||
| Not relieved by rest but by external application | 2 | |||||
| Not relieved by extenal application alone but by internal medication | 3 | 3 | ||||
| Present always in spite of medications | 4 | |||||
| 10 | Duration of Menstual bleed | 4–7days | 0 | NA | NA | NA |
| 3 days | 1 | |||||
| 2 days | 2 | |||||
| 1 day | 3 | |||||
| 11 | Intervel between two cycles | 25–29 days | 0 | NA | NA | NA |
| 35–39 days | 1 | |||||
| 40–45 days | 2 | |||||
| >45 days | 3 | |||||
| 12 | Hair fall | Absent | 0 | 0 | 0 | 0 |
| On washing | 1 | |||||
| Combing | 2 | |||||
| Simple stretching | 3 | |||||
| 13 | Hoarseness of voice | Absent | 0 | 0 | 0 | 0 |
| Present | 1 | |||||
| 14 | Cold intolerance | Absent | 0 | |||
| Present | 1 | 1 | 0 | 0 | ||
| Sum of all signs present | 27 | 5 | 3 | |||
Even though the earlier 2 scales, namely Billewicz diagnostic index and Zulewski's clinical score for hypothyroidism are widely used and much authentic, it does not address the common complaints in an Indian setting. This scoring [27] is a combination of 2 mutually similar score sheets, which includes the complaints applicable to females only. It also addresses features like hair fall, lethargy, gasping etc., which are commonly seen.
7.1. Important follow-up diagnostic and other test results
Even though fluctuations in the TSH values are possible in Hashimoto's thyroiditis, here the TSH values went higher to the level of 24.3 on 29.5.23 in spite of its initial success at the same dose as seen from the results TSH 0.724 on 18.1.23 which was earlier TSH 8.15 on 27.10.22. Within 4 days after the higher value, Ayurvedic medicines on along with the Levothyroxine in same dose was started. In six weeks the TSH value came down to normalcy on 19.7.23 to the level of 1.1 along with significant relief in the clinical complaints. This could be due to better bio-availability offered by the addition of Ayurvedic medicines to the prescription.
Levothyroxine was stopped as the TSH level found normal on 19.7.23 and only Ayurvedic prescription was continued. After 6 weeks on 3.10.23, the TSH level was at 2.26 showing normalcy. This indicates the Ayurvedic prescription alone, with no thyroxin supplements along with was able to keep TSH level in normalcy. At 11.3.24 the TSH levels were 3.16, showing normalcy and no noticeable presence of clinical features during this period.
The TPO levels which was more that 600 on 27.10.22 was reduced to 180 on 9.2.24 which shows the inflammatory activity due to Hashimoto's thyroiditis has also reduced. The systemic anti -inflammatory effect that could reduce generalised swelling and other symptoms in this patient could have helped to create a milieu interior that does not provoke auto immune activities in the body as seen by good response anti thyroid peroxidase levels in the serum. In the past two decades, Ayurveda has become popular choice of treatment in various autoimmune diseases such as Rheumatoid arthritis etc.
7.2. Intervention adherence and tolerability
The prescription was finalized after discussing the plan with the patient and taking her opinions regarding feasibility and compliance. The prescription was continued with regular weekly follow ups. This ensured intervention adherence and tolerability.
7.3. Adverse and unanticipated events
On 26-6-23 patient reported occasional mild stomach pain. In addition to the current medications, she was prescribed Dadimashtaka choornam. It is described in the context of Kaphaja atisara chikitsa. It is also a widely used choice for stomach pain due to various causes like dysentery, flatulence etc.
8. Discussion
8.1. Strengths and limitations
This case report demonstrates the need of matching clinical complaints to identify a known samprapti so that the clinician can adopt its treatment principles, medicines, pathya etc. Positive outcomes can be achieved when the treatment is attended on a case to case basis, in contrast to generalised supplementation irrespective of clinical presentation.
8.2. Discussion on relevant medical literature
In this patient, the treatment principles of pandu and sopham were brought in due to the similarity of clinical complaints with the textual descriptions of pandurogam and sopham. The selection of medicines from the context is largely based on empirical knowledge and relevance to the purpose of treatment in this case. A comprehensive prescription is generated after considering the opinions of the patient regarding compliance.
Primary indication of vyoshadi kashayam is pandu. From the ingredients and also from the beneficial outcome, it can be assumed that, it was working at the level of agni, with far reaching benefits at the level of dhatwagni and bhootagni. Mandoora vatakam is indicated in pandurogam, which is also indicated in ajarakam (reduced digestion) and sopham. It contains cow's urine, which is among those listed to be given [chapter 17, verse 17–19] in srotovibandham (obvious here by reduced sweating and constipation), agnimandyam (assumed from the reduced dhatwagni) and sluggish stomach (stimitasayah - assumed here by constipation and reduced digestion).
Avipathy choornam is a widely used safe laxative. It is indicated in Jwaram, Pandurogam, weak digestive power and in toxin related manifestations. It is considered ideal in Pitta diseases. Pandurogam is a pitta dominant disease. Laxation is an important treatment in Pitta diseases.
Kanchanara Guggulu is widely used medicine for galagandam. It has been a main object of various clinical studies in hypothyroidism in the past 2-3 decades. Dasamoola hareethaki is a popular choice for long term use in generalised edema. It is a broad-spectrum medicine which is also a mild laxative. Chandraprabha tablets, which is widely used in urinary system diseases was given here considering its diuretic potential in generalised swelling. The dominant ingredients of these 3 medicines also have Rasayana properties.
The Dosha status related manifestations reveal that the patient has presented a vata & kapha dominant status. When matched with the Nidana Panchaka, the features were similar to the disease Pandu and sopham. The hetu (causative factor) here is a systemic inflammatory activity (pakam – an act of pitta dosha) of autoimmune origin which had caused damages and degeneration (an act of Vata dosha) of thyroid gland, hampering its function in metabolism. As a sequel, stagnation happens at Rasadhatu, which is presented as increased features of asthayi rasadhatu, which are similar to the features of increased kaphadosha. The poorvaroopa and roopa are very much similar to those of pandurogam. Here the disease pandu has presented its important upadravam i.e. sopham also, which helped to confirm the diagnosis. Using the principles of panduroga chikitsa and sophachikitsa, selecting medicines from that context based on its suitability to the patient's clinical condition and willingness to follow the prescription for sufficient duration has become effective in reducing the sign and symptoms along with laboratory values. This shows the upsayam to the treatment along the lines of panduroga chiktsa.
The medications were effective to make Srotosodhanam (removing the stagnations in metabolic pathways) by reducing the vitiated Kapham, pacifying the Pittam and making Anulomana to the Vatadosha. The medicines in general worked as deepana, pachana and rookshanam in the situation to make sufficient Agnideepti at Dhatwagni level, and to make effective rookshanam by offering dryness in order to reduce the fluid retention at sites which referred in the texts as location of sopham i.e., between twak & mamsam.
Patients suffering from Hypothyroidism frequently approach Vaidyas for management of their refractory clinical complaints, alternate options for hormone supplementation and also in search of permanent cure for the illness. Many of such cases treated with Ayurveda are published with reduction in TSH values and improvement of clinical symptoms. Often a few cases of hypothyroidism with increased anti-thyroid peroxidase were also reported with obvious improvement after treatment. Seetha C et al., has reported the effectiveness of a treatment protocol containing rookshana, snehana, vamana and virechana followed by Shamana drug Varunadi kwatha bhavita shilajatu is followed in this case of HT. This protocol is found to be effective in clinical, biochemical and sonological aspects. In this case, reduction of TSH from 46 to 16 IU/ml and TPO from 208.7 to 32 IU/ml was reported before and after treatment. The same treatment protocol has been reported further as a case series of 5 cases with conspicuous reduction in TSH, TPO and Anti TG values in all. Seethadevi et al. has reported TPO value more than 1300 reduced to 299.5 IU/ml in a case of Hashimoto's thyroiditis, with Shodhana followed by shamana chikitsa.
This case presents improvements in clinical features, TSH and TPO values. The clinical presentation of the patient was unique being sopha dominant, where the samprapti of pandusopha is considered for correlation. Thus, treatment line similar to that of pandu and sopha was adopted here, along with medicines suggested in the context. The case study shows the effectiveness of Shamana Chikitsa, with no preceding Sodhana Chikitsa in autoimmune hypothyroidism.
8.3. Conclusion
Apart from a hormonal supplementation, management of hypothyroidism using Ayurvedic principles and practice involves a highly patient oriented medicine selection based on the clinical presentation and diagnostic analysis explained in Ayurvedic classics.
9. Patient's perspective
Patient responded to the consultations very positively and vowed full cooperation throughout the treatment. She was satisfied with the results obtained by the treatment and plans to continue it further for a longer duration.
Informed consent
Authors certify that they have obtained informed consent from the patient, where they have given their consent for reporting the case along with relevant clinical information in the journal, with due efforts to conceal identity.
Funding sources
None
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
- 1.Tiwari B.K., Ray I., Malhotra R.L. Directorate of health Services. Ministry of Health and Family Welfare; New Delhi: 2006. Policy Guidelines on National iodine deficiency Disorders control Programme-Nutrition and IDD cell; pp. 1–22. Government of India. [Google Scholar]
- 2.Unnikrishnan A.G., Kalra S., Sahay R.K., Bantwal G., John M., Tewari N. Prevalence of hypothyroidism in adults: an epidemiological study in eight cities of India. Indian J Endocrinol Metab. 2013;17(4):647–652. doi: 10.4103/2230-8210.113755. PMID: 23961480; PMCID: PMC3743364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Razvi S., Korevaar T.I.M., Taylor P. Trends, Determinants, and associations of treated hypothyroidism in the United Kingdom, 2005-2014. Thyroid. 2019 Feb;29(2):174–182. doi: 10.1089/thy.2018.0251. Epub 2019 . PMID: 30501570. [DOI] [PubMed] [Google Scholar]
- 4.Hollowell J.G., Staehling N.W., Flanders W.D., et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988–1994): National health and Nutrition examination Survey (NHANES III) J Clin Endocrinol Metab. 2002;87(2):489–499. doi: 10.1210/jcem.87.2.8182. [DOI] [PubMed] [Google Scholar]
- 5.Aoki Y., Belin R.M., Clickner R., et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002) Thyroid. 2007;17:1211–1223. doi: 10.1089/thy.2006.0235. [DOI] [PubMed] [Google Scholar]
- 6.Devaraj T.V., Salina S. Prevalence of hypothyroidism in Kannur; a coastal district in Kerala. Thyroid Res Pract. 2021;18(2):55–60. doi: 10.4103/trp.trp_1_22. [DOI] [Google Scholar]
- 7.Midgley John E.M. Variation in the biochemical response to L-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency. Endocrine Connections. 2015;4:196–205. doi: 10.1530/EC-15-0056. http://www.endocrineconnections.org [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hoermann R., Midgley J.E.M., Giacobino A., Eckl W.A., Wahl H.G., Dietrich J.W., Larisch R. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment. Clin Endocrinol. 2014;81:907–915. doi: 10.1111/cen.12527. [DOI] [PubMed] [Google Scholar]
- 9.Kalra S., Khandelwal S.K., Goyal A. Clinical scoring scales in thyroidology: a compendium. Indian Journal of Endocrinology and Metabolism. 2011;15(Suppl2):S89–S94. doi: 10.4103/2230-8210.83332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Billewicz W.Z., Chapman R.S., Crooks J., Day M.E., Gossage J., Wayne E., et al. Stastical Methods applied to the diagnosis of hypothyroidism. Q J Med. 1969;38:255–266. [PubMed] [Google Scholar]
- 11.Padmini, et al. Effect of Vamana karma in hypothyroidism: a Single case study. Int J Recent Sci Res. 2020;11(10):39899–39901. doi: 10.24327/ijrsr.2020.1110.5582. [DOI] [Google Scholar]
- 12.Ghaywate Ravindra B. Effect of ayurvedic medicine in hypothyroidism: a case study. World J Pharmaceut Res. 2020;9(10):948–953. [Google Scholar]
- 13.Meghna Lalit Nagar, Lamo Ringzin, et al. Ayurvedic management of hypothyroidism - a case report. J Pharm Res. 2023;22(2):98–102. doi: 10.18579/jopcr/v22.2.23.19. [DOI] [Google Scholar]
- 14.Dabhi Hetvi, Dr Deshpande Shailesh V., Dr. Deshpande Vaishali S. A Case Study on Ayurvedic Management of Hypothyroidism Tuijin Jishu/Journal of Propulsion Technology. 2023;44(3) [Google Scholar]
- 15.Priyavrat Sharma., editor. Charaka Samhita of Charaka. vol. 1. Chaukamba Orientalia; Varanasi: 2010. p. 130. (Sutra sthana). [chapter 18] verses 44–45. [Google Scholar]
- 16.Hari Sadasiva Sastri Paradakara. Hridayam Ashtanga, stanam Nidana. Chaukhamba Surabharti Prakashan; Varanasi: 2017. Pandurogasophavisarpanidanam, chapter 13, verse 4-6; p. 518. [Google Scholar]
- 17.Krishnan Vaidyar K.V., et al., editors. Sujanapriya commentary on Sahasrayogam (Malayalam) 37th ed. Vidyarambham publishers; Alappuzha: 2021. p. 55. verse 4. [Google Scholar]
- 18.Taradattapantha, Editor, Ashtanga Hridayam, Cikitsa stanam; Panduroga cikitsitam: [chapter 16], verse 16. Varanasi: Chowkhamba Sanskrit Series Office, 1979; 529.
- 19.Hari Sadasiva Sastri Paradakara, Editor, Ashtanga Hridayam, Kalpasiddhistanam, Virecanakalpam: [chapter 2], verse 21-23. Varanasi: Chaukhamba Surabharti Prakashan, 2017; 743.
- 20.Pandey Gyanendra. 2008. Galagandadyadhikara, verse 9,. Varanasi: Chowkhamba Sanskrit series Office; p. 432. Translator, Bhaishajya Ratnavali. [Google Scholar]
- 21.Hari Sadasiva Sastri Paradakara, Editor, Ashtanga Hridayam, Cikitsastanam, Swayadhucikitsitam, [chapter 17], verse 14-16. Varanasi: Chaukhamba Surabharti Prakashan, 2017; 706.
- 22.Pandey Gyanendra. 2008. Bhaishajya Ratnavali, arsadhikara, verse 14, Varanasi: Chowkhamba Sanskrit series Office; p. 354. Translator. [Google Scholar]
- 23.Sadasiva Sastri Paradakara Hari., editor. Ashtanga Hridayam, Sarvangasundara commentary of Arunadatta, Nidana stanam. Chaukhamba Surabharti Prakashan; Varanasi: 2017. p. 518. Pandurogasophavisarpanidanam: [chapter 13], verse 4-6. [Google Scholar]
- 24.Paradakara Hari Sadasiva Sastri. In: Panduroga cikitsitam. Hridayam Ashtanga, stanam Cikitsa., editors. Chaukhamba Surabharti Prakashan; Varanasi: 2017. p. 704. [chapter 16], verse 57. [Google Scholar]
- 25.Paradakara Hari Sastri., editor. 2017. Ashtanga Hridayam, Cikitsa stanam; Atisaracikitsitam, [chapter 9], verse 113-115. Varanasi: Chaukhamba Surabharti Prakashan. [Google Scholar]
- 26.Zulewski H., Muller B., Exer P., Miserez A.R., Staub J.J. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82:771–776. doi: 10.1210/jcem.82.3.3810. [DOI] [PubMed] [Google Scholar]
- 27.Karishma Singh, Anup B. Thakar A clinical study to evaluate the role of Triphaladya Guggulu along with Punarnavadi Kashaya in the management of hypothyroidism. Ayu. 2018;39(1):50–55. doi: 10.4103/ayu.AYU_62_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
